News

Filter

Current filters:

enzalutamide

1 to 9 of 12 results

Medivation and Astellas announce final results of Phase III enzalutamide trial in prostate cancer

Medivation and Astellas announce final results of Phase III enzalutamide trial in prostate cancer

29-01-2014

Medivation and Japanese drug major Astellas Pharma have announced final results on the primary and secondary…

Astellas PharmaenzalutamideMedivationOncologyPharmaceuticalResearchUSAXtandi

Medivation and Astellas reveal positive Phase III results for prostate cancer drug

Medivation and Astellas reveal positive Phase III results for prostate cancer drug

23-10-2013

Medivation and Japanese drug major Astellas Pharma have announced positive results from the Phase III…

Asia-PacificAstellas PharmaenzalutamideMedivationOncologyPharmaceuticalResearchXtandi

Astellas and Medivation file for approval of enzalutamide in Japan

24-05-2013

Japanese drug major Astellas Pharma (TYO: 4503) has submitted an application for marketing approval of…

Asia-PacificAstellas PharmaenzalutamideMedivationOncologyPharmaceuticalRegulationXtandi

Medivation and Astellas debut Xtandi in USA

14-09-2012

USA-based Medivation (Nasdaq: MDVN) and Japanese partner Astellas Pharma (TSE: 4503) yesterday announced…

Astellas PharmaenzalutamideMarkets & MarketingMedivationNorth AmericaOncologyPharmaceuticalXtandi

FDA backs Medivation and Astellas' prostate cancer drug Xtandi

03-09-2012

USA-based Medivation (Nasdaq: MDVN and Japanese drug major Astellas Pharma (TYO: 4503) say that the US…

Astellas PharmaBiotechnologyenzalutamideMedivationNorth AmericaOncologyPharmaceuticalRegulationXtandi

Phase III study shows enzalutamide offers significant benefit in prostate cancer

17-08-2012

USA-based Medivation (Nasdaq: MDVN) and Japanese drug major Astellas (TSE: 4503) has announced the publication…

Astellas PharmaenzalutamideMedivationOncologyPharmaceuticalResearch

PDUFA Action Date for Astellas enzalutamide; Urogenix facility to close

07-08-2012

The US Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) action date…

Astellas PharmaenzalutamideGenito-urinaryMedivationOncologyPharmaceuticalRegulationResearchUrogenixVaccines

1 to 9 of 12 results

Back to top